|
Plavix 300-mg Tablet Gets Nod From FDA
Sanofi-aventis and Bristol-Myers Squibb (BMS) said the FDA has approved their supplemental new drug application for a 300-mg tablet form of their antiplatelet drug Plavix.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives